Uzma Asghar

Uzma Asghar, Consultant Medical Oncologist, balances roles at The Royal Marsden NHS Foundation Trust and ConcR. Specializing in patient care and scientific innovation, she leads advancements in cancer treatment and research, shaping the future of oncology.
This profile isn't ready yet! Check back soon.

Uzma Asghar is an accomplished Consultant Medical Oncologist, splitting her time between prestigious roles in the healthcare sector. With a focus on patient care and scientific innovation, she dedicates 50% of her schedule to The Royal Marsden NHS Foundation Trust since August 2021, where she brings her expertise to the forefront of cancer treatment. Simultaneously, she serves as the Chief Scientific Officer at ConcR, a position she has held since December 2019. In this capacity, Asghar plays a pivotal role in shaping scientific strategies and advancing research initiatives, further solidifying her reputation as a leader in the field.

At North Middlesex University Hospital NHS Trust, Asghar's role encompasses two critical facets: as a Medical Oncology Consultant specializing in Breast and Acute Oncology Services and as the Chemotherapy Lead, contributing 50% of her time since September 2020. Her multifaceted approach ensures comprehensive patient care while driving advancements in treatment protocols. Prior to these roles, she served as a Senior Clinical Research Fellow at University College London Hospitals NHS Foundation Trust, focusing on early-phase drug clinical trials. Her tenure in clinical research, spanning institutions like The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, underscores her commitment to pushing the boundaries of oncology care.

Throughout her career journey, Asghar has consistently demonstrated a dedication to improving patient outcomes and advancing medical knowledge. Her contributions to clinical research, coupled with her hands-on experience in patient care, reflect a holistic approach to combating cancer. As a respected figure in the medical community, Asghar's work continues to drive progress in oncology, shaping the landscape of cancer treatment for years to come.

  • The Royal Marsden NHS Foundation Trust (Part-time): Consultant Medical Oncologist (50%), Aug 2021 - Present (2 yrs 11 mos)
  • ConcR (Part-time): Chief Scientific Officer (50%) - Current, Dec 2019 - Present (4 yrs 7 mos)
  • North Middlesex University Hospital NHS Trust (Part-time): Medical Oncology Consultant (Breast/AOS) and Chemotherapy Lead (50%), Sep 2020 - Present (3 yrs 10 mos)
  • University College London Hospitals NHS Foundation Trust (Full-time): Senior Clinical Research Fellow (NIHR Clinical Research Facility - Early Phase Drug Clinical Trials), Mar 2019 - Aug 2020 (1 yr 6 mos)
  • NHS Trust (Full-time): Medical Oncology Specialist Registrar (North London Network UCLH, Royal Free, North Middlesex), Nov 2009 - Aug 2020 (10 yrs 10 mos)
  • The Institute of Cancer Research (Full-time): Clinical Research Fellow (PhD; Dr Avon Fellow - Breast Cancer Now at ICR), Oct 2013 - Feb 2017 (3 yrs 5 mos)
  • The Royal Marsden NHS Foundation Trust (Full-time): Clinical Research Fellow (GI Unit), Jan 2009 - Oct 2009 (10 mos)
  • North Middlesex University Hospital NHS Trust (Full-time): Senior House Officer (ST2 Oncology and HIV), Sep 2007 - Jul 2008 (11 mos)
  • Barts Health NHS Trust (Full-time): Senior House Officer (ST1 A&E, Cardiology and Care of the Elderly), Aug 2006 - Sep 2007 (1 yr 2 mos)

Is this you? Would you like to update some of the details here?

Features: